EUVIMEDEUVIMED entdecken
Crossref

Liquiritin as a Tumor Suppressor Prevents the Development of Breast Cancer via the Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase 8 Signaling Pathway

Ping Li, Lili Yuan, Ying Jiang, Yue Chen, Manyu Zhang, Ling Jiang, Pengling Ge iD

DNA and Cell Biology · 2025

DOI: 10.1089/dna.2024.0249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DNA and Cell Biology, 2025. Verfasst von Ping Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Flavanones, ErbB Receptors, Breast Neoplasms, Glucosides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesErbB ReceptorsBreast NeoplasmsGlucosidesHumansFemaleCell ProliferationAnimalsApoptosisCell Line, TumorSignal TransductionReactive Oxygen SpeciesMiceMice, Inbred BALB CMice, NudeMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

apoptosisbreast cancercell proliferationliquiritinmitochondrial dysfunction

Substanzen

FlavanonesErbB ReceptorsliquiritinGlucosidesReactive Oxygen SpeciesEGFR protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Department of Biochemistry, School of Medical Laboratory Sciences, Heilongjiang Nursing College, Harbin, China.
  • School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China.

ORCID-Profile: Pengling Ge

Zitieren

APA

Li, P., Yuan, L., Jiang, Y., Chen, Y., Zhang, M., Jiang, L., & Ge, P. (2025). Liquiritin as a Tumor Suppressor Prevents the Development of Breast Cancer via the Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase 8 Signaling Pathway. DNA and Cell Biology. https://doi.org/10.1089/dna.2024.0249

Vancouver

Li P, Yuan L, Jiang Y, Chen Y, Zhang M, Jiang L, et al. Liquiritin as a Tumor Suppressor Prevents the Development of Breast Cancer via the Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase 8 Signaling Pathway. DNA and Cell Biology. 2025. doi:10.1089/dna.2024.0249

BibTeX
@article{Li2025,
  author = {Li, Ping and Yuan, Lili and Jiang, Ying and Chen, Yue and Zhang, Manyu and Jiang, Ling and Ge, Pengling},
  title = {Liquiritin as a Tumor Suppressor Prevents the Development of Breast Cancer via the Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase 8 Signaling Pathway},
  journal = {DNA and Cell Biology},
  year = {2025},
  doi = {10.1089/dna.2024.0249}
}
Kostenlos starten →